Atlas FDA

Exablate Model 4000 Type 1.0 and 1.1 Systems (“Exablate Neuro”)

FDA premarket approval P150038/S015 · decided 2023-07-18

Approval details

PMA number
P150038
Supplement
S015
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Labeling Change - PAS
Trade name
Exablate Model 4000 Type 1.0 and 1.1 Systems (“Exablate Neuro”)
Generic name
MR-guided focused ultrasound system
Applicant
Insightec
Date received
2021-06-11
Decision date
2023-07-18
Days to decision
767 days
Decision code
APPR
Product code
POH
Advisory committee
Neurology
Expedited review
No
Location
Tirat Carmel
Statement
Approval for a change to the prescribers labeling to include the post-approval study (PAS) results from the 5-year follow-up.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.